Revenue ($USD) : $1,022,843,000
R&D spend : $73,015,000.00
Employees : 2,600
Fiscal year end : 12/31/22
CEO : Daniel Scavilla

Globus Medical reported Street-beating Q2 results as it prepares for its merger with fellow spine tech company NuVasive. Globus shareholders would own about three-fourths of the company resulting from the merger, which would create the second-largest spine tech company in the world behind Medtronic. As of the writing of this description in early August, officials at both companies were sticking by plans to complete the deal in the present quarter — even as the Federal Trade Commission continues to scrutinize the merger. –CN